Non-invasive Spinal Cord Stimulation for Spasticity Control and Augmen
Non-invasive Spinal Cord Stimulation for Spasticity Control and Augmentation of Voluntary Motor Control in Individuals With Multiple Sclerosis
What it found
We found no results in the registry or in papers.
This trial finished 6 years ago. We found no results in the registry or in any paper that cites it.
What was tested
Treatment tested
- transcutaneous spinal cord stimulation
What it measured
Main measures
Modified Ashworth Scale
24 hours
Spasticity
Other measures (3)
10-m walk test
24 hours
Walking and mobility2-min walk test
24 hours
Walking and mobilityTimed up an go test
24 hours
Who could take part
Relapsing and progressive · 18 to 80
Show the full criteria
Inclusion criteria
* confirmed diagnosis of relapsing-remitting, primary- or secondary-progressive MS * lower-limb spasticity
Exclusion criteria
* acute relapse of MS * other neuromuscular diseases * active and passive implants at vertebral level T9 or caudally * dermatological issues at stimulation site * pregnancy
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
Epidural spinal cord stimulation (SCS) is currently regarded as one of the most promising intervention methods to improve motor function in individuals with severe spinal cord injury. In parallel, an increasing number of studies is suggesting that noninvasive SCS can improve spasticity and residual motor control in the same subject population. The present study explores whether single sessions of noninvasive SCS would improve walking performance and ameliorate spasticity in individuals with multiple sclerosis.
Loading reviews and guidelines…
History
Started
Dec 2017
Main results due
Jul 2020
Finished
Jul 2020